RedHill Biopharma (RDHL) Cash & Equivalents (2011 - 2025)
RedHill Biopharma (RDHL) posted quarterly Cash & Equivalents of $4.6 million for Q4 2025, little changed year-over-year from $4.6 million in Q4 2024, and little changed quarter-over-quarter from $4.6 million in Q2 2025.
RedHill Biopharma (RDHL) Cash & Equivalents (2011 - 2025) Analysis & Trends
RedHill Biopharma (RDHL) has reported Cash & Equivalents for 15 consecutive years, with $4.6 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Cash & Equivalents changed 0.0% year-over-year to $4.6 million; the TTM figure through Dec 2025 stood at $4.6 million (changed 0.0% YoY), while the FY2025 annual figure was $4.6 million, down 17.09% from the prior year.
- Cash & Equivalents steadied at $4.6 million in Q4 2025 per RDHL's latest filing, from $4.6 million in the prior quarter.
- Across five years, Cash & Equivalents topped out at $76.0 million in Q1 2021 and bottomed at $4.6 million in Q4 2024.
- Historically, Cash & Equivalents has averaged $28.0 million across 5 years, with a median of $20.0 million in 2022.
- Annual changes were most pronounced in 2021 — Cash & Equivalents surged 78.53% — and 2024, when it tumbled 76.88%.
- RedHill Biopharma's Cash & Equivalents stood at $29.5 million in 2021, then slumped by 32.25% to $20.0 million in 2022, then changed by 0.0% to $20.0 million in 2023, then sank by 76.88% to $4.6 million in 2024, then changed by 0.0% to $4.6 million in 2025.
- Business Quant data shows RDHL's Cash & Equivalents at $4.6 million in Q4 2025, $4.6 million in Q2 2025, and $4.6 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | 1.11 Bn |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | 3.66 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | 1.48 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 2.89 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 1.80 Bn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 886.50 Mn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 332.40 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | 164.00 Mn |
| 10 | RedHill Biopharma | 2.05 Bn | 2.05 Bn | - | 4.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.62 Mn |
| Jun 30, 2025 | 4.62 Mn |
| Dec 31, 2024 | 4.62 Mn |
| Jun 30, 2024 | 7.28 Mn |
| Dec 31, 2023 | 19.97 Mn |
| Jun 30, 2023 | 19.97 Mn |
| Mar 31, 2023 | 17.57 Mn |
| Dec 31, 2022 | 19.97 Mn |
| Sep 30, 2022 | 29.47 Mn |
| Jun 30, 2022 | 29.47 Mn |
| Mar 31, 2022 | 29.47 Mn |
| Dec 31, 2021 | 29.47 Mn |
| Sep 30, 2021 | 51.82 Mn |
| Jun 30, 2021 | 75.97 Mn |
| Mar 31, 2021 | 75.97 Mn |
| Dec 31, 2020 | 29.30 Mn |
| Sep 30, 2020 | 29.02 Mn |
| Jun 30, 2020 | 81.61 Mn |
| Mar 31, 2020 | 81.61 Mn |
| Dec 31, 2019 | 29.02 Mn |